Every day, thousands of MRI (magnetic resonance imaging) scans are taken from different patients. Up to now, radiologists have had to analyze each individual image manually when looking for tumors. Now artificial intelligence is helping to make the diagnosis: FUSE-AI, a start-up based in Hamburg, has developed a system that can detect and classify tumors on MRI scans. The system not only highlights abnormalities in the image, it even assesses whether the tumor is benign or malignant. This helps radiologists to detect significant tissue changes faster and more reliably. For the intelligent algorithm used to analyze the MRI images, the North-German start-up relies on IT resources from the Open Telekom Cloud. Features at a glance:

  • FUSE-AI aims to improve cancer detection with artificial intelligence
  • Self-developed algorithm analyzes MRI images, detects and highlights abnormalities such as carcinomas, and outputs an assessment as to its malignancy
  • Leverages flexibly scalable, reliable and secure IT resources from the Open Telekom Cloud

Download the flyer "FUSE-AI"



The founders of the Hamburg-based start-up FUSE-AI already had a track record in the software development field. They developed apps for the medical sector. "Over time, it became increasingly clear that artificial intelligence would become an important tool in medicine," says Maximilian Waschka, one of the founders of FUSE-AI. "From this we had the idea to use machine learning, especially neural networks, to support physicians to make diagnoses." In 2015, four Hamburg entrepreneurs turned their idea into reality and designed initial versions of an algorithm that can detect symptoms of cancer automatically from tomography images. Their artificial intelligence was aimed at reliably finding, highlighting and classifying tumors.

"This is how we can contribute to the detection of many common diseases even more reliably and quickly. We not only reduce the effort and costs involved, but thanks to artificial intelligence we’re also increasing the patients’ chances of being cured.”  

Sabrina Reimers-Kipping, PhD biochemist and co-founder of FUSE-AI


An MRI scan provides more than 2,000 images - per patient and per exam in the scanner. For a radiologist, the task is then to scrutinize the images for irregularities. They must also recognize and ignore so-called artifacts, or false alarms that may arise from errors in the imaging process. At the same time, they have to spot real carcinomas and ideally recognize whether the tumor is benign or malignant. A complex task that artificial intelligence can solve. Provided enormous computing power is available. But there is a limitation: “Our demand fluctuates. We only need very high capacities for the image analysis," says Dirk Schäfer, an expert in machine learning and co-founder of FUSE-AI. "Keeping this level of IT resources permanently available for such analyses would be very uneconomic." So the recent start-up was looking for flexible cloud resources to run the solution reliably and securely. "Another key advantage is the time we save. Because the platform services of the Open Telekom Cloud, such as the distributed Message Service (DMS), take on administrative tasks for us. This allows our developers to focus more on their core tasks," says Schäfer.



The Hamburg-based entrepreneurs applied to Telekom's start-up program: TechBoost. The ICT provider supports suitably qualified young companies with software-based business models with 100,000 euros of start-up funding for computing power from the Open Telekom Cloud, the public cloud service offered by Deutsche Telekom. In addition, TechBoost start-ups receive discounts on mobile, fixed-network and internet tariffs, and sales and marketing support. With their innovative solution, the founders of FUSE-AI qualified for TechBoost at the first attempt and are now making use of the scalable IT resources from the multi-certified, highly secure data centers of Deutsche Telekom in Saxony-Anhalt.



From 2018 onwards FUSE-AI will provide radiologists with round-the-clock diagnostic support from the cloud on demand. "The Open Telekom Cloud is a wonderful tool that provides us with the flexibility and scalability to implement a solution of this kind," says Schäfer. But that was just the beginning. FUSE-AI also intends to support physicians in other diagnostic imaging procedures. To achieve this, the founders, in conjunction with specialists such as dermatologists, have developed a dermatoscope, a device which takes pictures of the skin. Like the MRI images, these are also analyzed in the cloud using FUSE-AI’s artificial intelligence. "This is how we can contribute to detecting many common diseases even more reliably and quickly," says Sabrina Reimers-Kipping, a PhD biochemist and co-founder of FUSE-AI. “This not only reduces the effort and costs involved, but thanks to artificial intelligence it also increases the patients' chances of being cured.”


Privacy Settings

This website uses cookies and similar technologies. These are small text files that are stored and read on your computer. By clicking on "Accept all", you accept the processing, the creation of individual user profiles across websites and partners, and the transfer of your data to third parties, some of whom process your data in countries outside the European Union (GDPR Art. 49). Details can be found in section 3 of the privacy information. The data is used for analysis, retargeting and for playing out personalized content and advertising on Deutsche Telekom Healthcare and Security Solutions GmbH sites and third-party sites. Further information, including information on data processing by third-party providers and the possibility of revocation, can be found in the settings and in our privacy information. Here you can continue only with the necessary tools.

Privacy Settings

In order to provide you with an optimal website experience, we use cookies. These include cookies for the operation and optimization of the site as well as for services such as text or video chat and for advertising based on your online usage behavior. This allows us, for example, to detect if you visit our pages repeatedly from the same device. We would like to give you the choice which cookies you allow:

Required cookies

These cookies are required to enable you to navigate through the websites and use key functions.

They support basic functions, such as order processing in the online shop and access to secured areas of the web page. They also serve the purpose of performing an anonymous analysis of user patterns, which we use to continuously develop and improve our web pages for you.

Services by other companies (independent third party providers)

Deutsche Telekom Healthcare and Security Solutions GmbH’s websites include links to third party service providers, who provide their services under their own responsibility.

When you visit web pages of Deutsche Telekom Healthcare and Security Solutions GmbH, cookies or similar technologies record data and send it to third parties, in part for Deutsche Telekom Healthcare and Security Solutions GmbH’s own purposes. The scope, purpose and legal basis on which further processing is carried out for the third party’s own purposes can be found in the third party’s data privacy information. Information on the independent third party providers can be found in the data privacy information.

Change SettingsSave SettingsAccept All